Skip to content

Affirmagen 719211

by Ortho-Clinical Diagnostics

Affirmagen 719211 is a medical device made by Ortho-Clinical Diagnostics, listed in FDA GUDID since 22 Oct 2014 (UDI-DI 10758750003914), registry data as of 23 Oct 2026.

Listed FDA GUDID listing, no authorization on record

Valid until

Not applicable

Database listing, no authorization

FDA recalls

Not checked

No FDA submission to match recalls against

Documents

None

No authorization documents

Trust

Unverified

Source GUDID, synced 23 Oct 2026.

Regulatory status

as of registry sync 23 Oct 2026

RegionAuthorizationNumberDateStatus
United StatesGUDID listing Number10758750003914 UDI-DI Date22 Oct 2014ListedStatusListed GUDID: in commercial distribution

Official records

Coverage

1 jurisdiction

United States of America
  • Active
  • Expiring
  • Withdrawn
  • Listed
  • Not covered

United States — GUDID listing Listed

Specification

GUDID

Trade name
Affirmagen
Generic name
Reverse ABO grouping reagent red blood cell (A1/A2/B/AB/O) IVD, kit, agglutination
Model / Ref / Catalog
719211
Primary DI / UDI-DI
10758750003914
GMDN term
Reverse ABO grouping reagent red blood cell (A1/A2/B/AB/O) IVD, kit, agglutination
GUDID distribution status
In Commercial Distribution

Other devices from Ortho-Clinical Diagnostics

See all devices from Ortho-Clinical Diagnostics →

Properties

  • Prescription use
  • Convenience kit
  • Lot / batch number
  • Expiration date
Other properties (11, all answered No)